What Conditions does Pembrolizumab Solution, Reconstituted (Recon Soln) Treat?

  • malignant melanoma
  • a type of skin cancer
  • PD-L1 positive non-small cell lung cancer
  • squamous cell carcinoma of head and neck
  • a type of cancer of the lymph nodes called Hodgkin's lymphoma
  • EGFR negative
  • ALK negative
  • non-small cell lung cancer
  • cancer of the urinary tract lining
  • microsatellite instability-high solid cancer
  • microsatellite instability-high colorectal cancer
  • HER2-positive gastric adenocarcinoma
  • early-stage triple-negative breast cancer
  • carcinoma cancer of the cervix
  • primary mediastinal large B-cell lymphoma
  • PD-L1 positive cervical cancer
  • non-small cell lung cancer
  • liver cell carcinoma
  • a type of skin cancer called Merkel cell carcinoma
  • added therapy to improve treatment of melanoma
  • renal cell carcinoma
  • PD-L1 expressing triple-negative breast cancer
  • PD-L1 positive squamous cell carcinoma of the esophagus
  • cancer in the lining of the uterus
  • non-muscle invasive bladder cancer with carcinoma in situ
  • solid malignant tumor with high mutation burden
  • cancer of the squamous cells in the skin
  • cancer of the esophagus
  • cancer of gallbladder or bile ducts
  • HER2-negative gastric or gastroesophageal junction adenocarcinoma

Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.

CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.